HOME

Newsletter Subscription
Print

Heterologous immunity to Epstein-Barr virus: dissecting the role of cross-reactive CD8 T cells in mediating disease outcome in children, young adults and the elderly.


Category

FP7 Project with U.S. partner

Short name and number

EBV HORIZONS (219603)

Area

Health

Description

Viral infections, and the associated tumours and disease that they cause, are a major source of economic and social burden in Europe. There is an urgent need to understand the basic mechanisms behind their pathogenesis to accelerate the rational design of vaccines and therapeutics. The training of highly skilled immunologists is vital to support this process.

Participating Countries

United Kingdom and United States.

Name of US Partner

UNIVERSITY OF MASSACHUSETTS

Contact

CARDIFF UNIVERSITY (UK) / BODYCOMBE Nick

See more

BILAT-USA (Grant Agreement no: 244434) and Link2US (Grant Agreement no: 244371) Projects are co-funded by the European Union’s Capacities Programme on International Cooperation under the 7th Framework Programme for Research and Technological Cooperation.